Publications in VIVO

Co-author Network

Co-investigator Network

Mara McAdams DeMarco, PhD

Person

Positions

Associate Professor, New York University Grossman School of Medicine

Clinical Disciplines

Publications
Research
Other
View All

Selected Publications

article
1. Neighborhood Segregation and Access to Live Donor Kidney Transplantation.. JAMA internal medicine. 184:402-413. 2024
2. Authors' Reply: Lipid Management and Interactions with Immunosuppressants in Kidney Transplant Patients: Some Opinions and Prospects. Journal of the American Society of Nephrology. 2024
3. COVID-19 and Access to Kidney Transplantation for Older Candidates in the United States: A National Registry Study. Kidney Medicine. 2024
4. ChatGPT Solving Complex Kidney Transplant Cases: A Comparative Study With Human Respondents. Clinical Transplantation. 2024
5. Obesogenic Medication Use in End‐Stage Kidney Disease and Association With Transplant Listing. Clinical Transplantation. 2024
6. Severe Polypharmacy Increases Risk of Hospitalization Among Older Adults With Inflammatory Bowel Disease. American Journal of Gastroenterology. 2024
7. Sexual bother and sexual activity before and after kidney transplantation. American Journal of Transplantation. 2024
8. Sleep Disorders and Dementia Risk in Older Patients with Kidney Failure. Clinical Journal of the American Society of Nephrology. 2024
9. Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records. Clinical Transplantation. 2024
10. The Impact of Kidney Transplantation on a Breadth of Cognitive Measures. American Journal of Kidney Diseases. 2024
11. Using Photovoice to Explore the Lived Environment and Experience of Older Adults with Frailty on their Kidney Transplant Journey. Kidney360. 2024
12. Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease. Circulation. 2023
13. Cognitive Dysfunction in Liver Disease and Its Implications for Transplant Candidates. Current Transplantation Reports. 2023
14. Delirium in Liver Transplantation. Current Transplantation Reports. 2023
15. Evolving Trends in Kidney Transplant Outcomes Among Older Adults: A Comparative Analysis Before and During the COVID-19 Pandemic. Transplantation Direct. 2023
16. Frailty Assessment as Part of Transplant Listing: Yes, No, or Maybe?. Clinical Kidney Journal. 2023
17. Incidence of Statin-Associated Adverse Events in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology. 2023
18. Sleep duration and cognitive function among older adults with chronic kidney disease – results from the National Health and Nutrition Examination Survey (2011-2014). Nephrology Dialysis Transplantation. 2023
19. Chronic kidney disease, physical activity and cognitive function in older adults—results from the National Health and Nutrition Examination Survey (2011–2014). Nephrology Dialysis Transplantation. 2022
20. Delirium, Changes in Cognitive Function, and Risk of Diagnosed Dementia After Kidney Transplantation. American Journal of Transplantation. 2022
21. Depressive Symptoms at Kidney Transplant Evaluation and Access to the Kidney Transplant Waitlist. Kidney International Reports. 2022
22. Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentin. Journal of Clinical Epidemiology. 2022
23. Harms in Systematic Reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harms. Journal of Clinical Epidemiology. 2022
24. Hurricanes and Mortality among Patients Receiving Dialysis. Journal of the American Society of Nephrology. 2022
25. Increasing rates of parathyroidectomy to treat secondary hyperparathyroidism in dialysis patients with Medicare coverage. Surgery. 2022
26. Long-Term Trajectories of Frailty and Its Components After Kidney Transplantation. The Journals of Gerontology: Series A. 2022
27. Moving toward clinical implementation of the physical frailty phenotype in kidney transplantation. American Journal of Transplantation. 2022
28. Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients. Surgery. 2022
29. Revision of frailty assessment in kidney transplant recipients: Replacing unintentional weight loss with CT-assessed sarcopenia in the physical frailty phenotype. American Journal of Transplantation. 2022
30. Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia. Nephrology Dialysis Transplantation. 2022
31. Sleep disorders and the development of Alzheimer's disease among U.S. Medicare beneficiaries. Journal of the American Geriatrics Society. 2022
32. Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care. Clinical Kidney Journal. 2022
33. Ambient air pollution and posttransplant outcomes among kidney transplant recipients. American Journal of Transplantation. 2021
34. Comparing outcomes of third and fourth kidney transplantation in older and younger patients. American Journal of Transplantation. 2021
35. Development and Validation of an Inflammatory-Frailty Index for Kidney Transplantation. The Journals of Gerontology: Series A. 2021
36. Frailty, Age, and Postdialysis Recovery Time in a Population New to Hemodialysis. Kidney360. 2021
37. High-dose opioid utilization and mortality among individuals initiating hemodialysis. BMC Nephrology. 2021
38. Inconsistencies in the association of clinical factors with the choice of early steroid withdrawal across kidney transplant centers: A national registry study. Clinical Transplantation. 2021
39. Pre-kidney transplant unintentional weight loss leads to worse post-kidney transplant outcomes. Nephrology Dialysis Transplantation. 2021
40. The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study. Liver International. 2021
41. Association of Socioeconomic Status and Comorbidities with Racial Disparities during Kidney Transplant Evaluation. Clinical Journal of the American Society of Nephrology. 2020
42. Benzodiazepines, Codispensed Opioids, and Mortality among Patients Initiating Long-Term In-Center Hemodialysis. Clinical Journal of the American Society of Nephrology. 2020
43. Differences Between Cystatin C– and Creatinine-Based Estimated GFR—Early Evidence of a Clinical Marker for Frailty. American Journal of Kidney Diseases. 2020
44. Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function. Journal of the American Society of Nephrology. 2020
45. Economic impacts of alternative kidney transplant immunosuppression: A national cohort study. Clinical Transplantation. 2020
46. Functional independence, access to kidney transplantation and waitlist mortality. Nephrology Dialysis Transplantation. 2020
47. Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data. Clinical Transplantation. 2020
48. Interventions Made to Preserve Cognitive Function Trial (IMPCT) study protocol: a multi-dialysis center 2x2 factorial randomized controlled trial of intradialytic cognitive and exercise training to preserve cognitive function. BMC Nephrology. 2020
49. Interventions to Preserve Cognitive Functioning among Older Kidney Transplant Recipients. Current Transplantation Reports. 2020
50. Outcome implications of benzodiazepine and opioid co‐prescription in kidney transplant recipients. Clinical Transplantation. 2020
51. Prevalence of frailty among kidney transplant candidates and recipients in the United States: Estimates from a National Registry and Multicenter Cohort Study. American Journal of Transplantation. 2020
52. The Long Road to Kidney Transplantation. Clinical Journal of the American Society of Nephrology. 2020
53. A donor risk index for graft loss in pediatric living donor kidney transplantation. American Journal of Transplantation. 2019
54. Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology. 2019
55. Induction immunosuppression agents as risk factors for incident cardiovascular events and mortality after kidney transplantation. American Journal of Transplantation. 2019
56. Prehabilitation prior to kidney transplantation: Results from a pilot study. Clinical Transplantation. 2019
57. Prescription opioid use before and after heart transplant: Associations with posttransplant outcomes. American Journal of Transplantation. 2019
58. Survival benefit of accepting livers from deceased donors over 70 years old. American Journal of Transplantation. 2019
59. Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation. Nephrology. 2019
60. Dementia, Alzheimer’s Disease, and Mortality after Hemodialysis Initiation. Clinical Journal of the American Society of Nephrology. 2018
61. Pre-Kidney Transplant Lower Extremity Impairment and Post-Kidney Transplant Mortality. American Journal of Transplantation. 2018
62. Pre-kidney transplant lower extremity impairment and transplant length of stay: a time-to-discharge analysis of a prospective cohort study. BMC Geriatrics. 2018
63. The Role of Bicarbonate in Cognition. Clinical Journal of the American Society of Nephrology. 2018
64. Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort. Arthritis Care and Research. 2016
65. Changes in body mass index and obesity risk in married couples over 25 years. American Journal of Epidemiology. 2016
66. Dual-energy computed tomography has limited sensitivity for non-tophaceous gout: A comparison study with tophaceous gout. BMC Musculoskeletal Disorders. 2016
67. Early Hospital Readmission after Simultaneous Pancreas-Kidney Transplantation: Patient and Center-Level Factors. American Journal of Transplantation. 2016
68. Effects of Lowering Glycemic Index of Dietary Carbohydrate on Plasma Uric Acid Levels: The OmniCarb Randomized Clinical Trial. Arthritis and Rheumatology. 2016
69. Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective Cohort Study. Annals of Surgery. 2016
70. Gout in older adults: The atherosclerosis risk in communities study. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2016
71. Individual Frailty Components and Mortality In Kidney Transplant Recipients. Transplantation. 2016
72. Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus. American Journal of Transplantation. 2016
73. Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Kidney Diseases. 2016
74. Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study. Mayo Clinic Proceedings. 2016
75. Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study. Thrombosis Research. 2016
76. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis. BMC Nephrology. 2016
77. Changes in frailty after kidney transplantation. Journal of the American Geriatrics Society. 2015
78. Frailty and cognitive function in incident hemodialysis patients. Clinical Journal of the American Society of Nephrology. 2015
79. Frailty and mortality in kidney transplant recipients. American Journal of Transplantation. 2015
80. Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients. Transplantation. 2015
81. Perceived frailty and measured frailty among adults undergoing hemodialysis: A cross-sectional analysis. BMC Geriatrics. 2015
82. Perceptions about hemodialysis and transplantation among African American adults with end-stage renal disease: Inferences from focus groups. BMC Nephrology. 2015
83. Physical Function, Hyperuricemia, and Gout in Older Adults. Arthritis Care and Research. 2015
84. Plasma urate and risk of a hospital stay with AKI: The atherosclerosis risk in communities study. Clinical Journal of the American Society of Nephrology. 2015
85. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: The German Chronic Kidney Disease (GCKD) study. Nephrology Dialysis Transplantation. 2015
86. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome. Annals of the Rheumatic Diseases. 2015
87. Age and sex disparities in discussions about kidney transplantation in adults undergoing dialysis. Journal of the American Geriatrics Society. 2014
88. Health-related and psychosocial concerns about transplantation among patients initiating dialysis. Clinical Journal of the American Society of Nephrology. 2014
89. Patient- And Provider-Reported Information about Transplantation and Subsequent Waitlisting. Journal of the American Society of Nephrology. 2014
90. Racial differences in gout incidence in a population-based cohort: Atherosclerosis risk in communities study. American Journal of Epidemiology. 2014
91. Sequelae of early hospital readmission after kidney transplantation. American Journal of Transplantation. 2014
92. Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population. American Journal of Epidemiology. 2014
93. The association of spousal smoking status with the ability to quit smoking: The atherosclerosis risk in communities study. American Journal of Epidemiology. 2014
94. Trends in kidney transplant outcomes in older adults. Journal of the American Geriatrics Society. 2014
95. A urate gene-by-diuretic interaction and gout risk in participants with hypertension: Results from the ARIC study. Annals of the Rheumatic Diseases. 2013
96. Frailty and early hospital readmission after kidney transplantation. American Journal of Transplantation. 2013
97. Frailty and falls among adult patients undergoing chronic hemodialysis: A prospective cohort study. BMC Nephrology. 2013
98. Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. Journal of the American Geriatrics Society. 2013
99. Risk factors for incident hyperuricemia during mid-adulthood in African American and White men and women enrolled in the ARIC cohort study. BMC Musculoskeletal Disorders. 2013
100. Activity of daily living disability and dialysis mortality: Better prediction using metrics of aging. Journal of the American Geriatrics Society. 2012
101. Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study. Arthritis Research and Therapy. 2012
102. Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: The Atherosclerosis Risk in Communities cohort study. Arthritis and Rheumatism. 2012
103. Early hospital readmission after kidney transplantation: Patient and center-level associations. American Journal of Transplantation. 2012
104. Hypertension and the Risk of Incident Gout in a Population-Based Study: The Atherosclerosis Risk in Communities Cohort. Journal of Clinical Hypertension. 2012
105. Incident gout in women and association with obesity in the Atherosclerosis Risk in Communities (ARIC) study. American Journal of Medicine. 2012
106. Recipient age and time spent hospitalized in the year before and after kidney transplantation. Transplantation. 2012
107. Hypertension status, treatment, and control among spousal pairs in a middle-aged adult cohort. American Journal of Epidemiology. 2011
108. Obesity and younger age at gout onset in a community-based cohort. Arthritis Care and Research. 2011
109. Reliability and sensitivity of the self-report of physician-diagnosed gout in the Campaign Against Cancer and Heart Disease and the Atherosclerosis Risk in the Community cohorts. Journal of Rheumatology. 2011
110. Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: The ARIC study. Preventive Medicine. 2010
111. Observation plans in longitudinal studies with time-varying treatments. Statistical Methods in Medical Research. 2009
112. Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiology and Drug Safety. 2008
113. Estimating the extent of reporting to FDA: A case study of statin-associated rhabdomyolysis. Pharmacoepidemiology and Drug Safety. 2008
114. Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: Revisiting the Weber effect. Pharmacoepidemiology and Drug Safety. 2008
115. Comparison of self-reported and measured BMI as correlates of disease markers in U.S. adults. Obesity. 2007
116. The concomitant prescribing of ethinyl estradiol/drospirenone and potentially interacting drugs. Contraception. 2007
document
1. Development and Validation of an Abridged Physical Frailty Phenotype for Clinical Use: A Cohort Study Among Kidney Transplant Candidates 2023